← Back to Clinical Trials
Recruiting NCT07724977

NCT07724977 Comparative Effects of Closed Kinetic Chain Exercises and Thrower's Ten Exercises in Glenohumeral Instability

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07724977
Status Recruiting
Phase —
Sponsor Riphah International University
Condition Instability, Joint
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-10-15
Primary Completion 2026-08-15

Eligibility & Interventions

Sex Male only
Min Age 16 Years
Max Age 25 Years
Study Type INTERVENTIONAL
Interventions
closed kinetic chain exercisesthrower's ten exercises

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-10-15 with a primary completion date of 2026-08-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study is randomized and single-blinded. Ethical approval is taken from ethical committee of Riphah International University, Lahore. Participants who meet the inclusion criteria will be enrolled and allocated in group A \& B through sealed envelope method by Non-probability Convenient random sampling technique. Subjects in Group A will receive closed kinetic chain exercises. Group B will receive thrower's ten exercises.

Eligibility Criteria

Inclusion Criteria: * Male bowlers are included in this study * Healthy athletes with age group 16-25y * Athletes having 2 years of bowling experience Exclusion Criteria: * Bowlers with prior history of trauma and shoulder injuries from past 6 months bowlers with any medical issues such as hypertension, any , neurological , cardiovascular and psychological problems * if athlete suffered from any upper extremity orthopedic or musculoskeletal injury from last 6 months

Contact & Investigator

Central Contact

Amna Shahid, t-dpt

✉ amna.shahid@riphah.edu.pk

📞 0334-4512823

Principal Investigator

Sidra Rabbani, DPT

PRINCIPAL INVESTIGATOR

Study Principal Investigator

Frequently Asked Questions

Who can join the NCT07724977 clinical trial?

This trial is open to male participants only, aged 16 Years or older, up to 25 Years, studying Instability, Joint. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07724977 currently recruiting?

Yes, NCT07724977 is actively recruiting participants. Contact the research team at amna.shahid@riphah.edu.pk for enrollment information.

Where is the NCT07724977 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07724977 clinical trial?

NCT07724977 is sponsored by Riphah International University. The principal investigator is Sidra Rabbani, DPT at Study Principal Investigator. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology